# EXL01 listing is produced correctly

    Code
      result
    Output
      Listing of Exposure to Study Drug
      
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————
                                                      Study Day   Study Day                                         
      Treatment   Center/Subject ID       Visit         From         To       Dose   Unit   Frequency      Route    
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————
      A: Drug X     BRA-1/id-105        SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       720     mg      ONCE      SUBCUTANEOUS
                                      WEEK 2 DAY 15      15          15       480     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       480     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 5 DAY 36      36          36       720     mg      ONCE      INTRAVENOUS 
                    BRA-1/id-134        SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 2 DAY 15      15          15       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 5 DAY 36      36          36       960     mg      ONCE      INTRAVENOUS 
                     BRA-1/id-42        SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       720     mg      ONCE      SUBCUTANEOUS
                                      WEEK 2 DAY 15      15          15       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       480     mg      ONCE      INTRAVENOUS 
                                      WEEK 5 DAY 36      36          36       480     mg      ONCE      INTRAVENOUS 
                     BRA-1/id-93        SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 2 DAY 15      15          15       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       960     mg      ONCE      SUBCUTANEOUS
                                      WEEK 5 DAY 36      36          36       1200    mg      ONCE      INTRAVENOUS 
                    BRA-11/id-217       SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       480     mg      ONCE      SUBCUTANEOUS
                                      WEEK 2 DAY 15      15          15       720     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 5 DAY 36      36          36       960     mg      ONCE      INTRAVENOUS 
                    BRA-11/id-345       SCREENING        -1          -1       960     mg      ONCE      SUBCUTANEOUS
                                        BASELINE          1           1       1200    mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 2 DAY 15      15          15       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       1200    mg      ONCE      INTRAVENOUS 
                                      WEEK 5 DAY 36      36          36       1440    mg      ONCE      INTRAVENOUS 
                    BRA-11/id-397       SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 
                                        BASELINE          1           1       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 1 DAY 8        8           8       1200    mg      ONCE      INTRAVENOUS 
                                      WEEK 2 DAY 15      15          15       960     mg      ONCE      INTRAVENOUS 
                                      WEEK 3 DAY 22      22          22       1200    mg      ONCE      INTRAVENOUS 
                                      WEEK 4 DAY 29      29          29       1200    mg      ONCE      SUBCUTANEOUS
                                      WEEK 5 DAY 36      36          36       1200    mg      ONCE      INTRAVENOUS 
                    BRA-11/id-50        SCREENING        -1          -1       960     mg      ONCE      INTRAVENOUS 

